Go Back   HER2 Support Group Forums > Clinical Trials
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Display Modes
Old 10-18-2009, 01:31 PM   #1
Senior Member
Rich66's Avatar
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Metformin and Temsirolimus: Metastatic or Unresectable Solid Tumor (Ontario CA)


Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), April 2008
First Received: April 15, 2008 Last Updated: October 8, 2008 History of Changes
Sponsored by: London Regional Cancer Program at London Health Sciences Centre
Information provided by: National Cancer Institute (NCI) ClinicalTrials.gov Identifier: NCT00659568
Purpose RATIONALE: Metformin and temsirolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
PURPOSE: This phase I trial is studying the side effects and best dose of metformin when given together with temsirolimus in treating patients with metastatic or unresectable solid tumor or lymphoma.

Condition Intervention Phase Breast Cancer
Endometrial Cancer
Kidney Cancer
Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Drug: metformin hydrochloride
Drug: temsirolimus
Phase 1

Other Metformin studies:
Rich66 is offline   Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

All times are GMT -7. The time now is 11:46 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2019, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter